Engineered Antibody Neutralizes All Four Dengue Serotypes

via www.sail-world.com

Researchers have designed an antibody that targets all four serotypes of dengue, sparking hopes for the first viable dengue therapeutic

A multinational research team comprising scientists, engineers and drug developers have joined forces to develop a viable dengue therapeutic that targets all dengue serotypes. Their results, published in Cell, come as welcome news at a time were an estimated 400 million people are infected with dengue each year.

Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), Duke-NUS Graduate School of Medicine (Duke-NUS), National University of Singapore (NUS) and Nanyang Technological University (NTU) have collaborated with the Massachusetts Institute of Technology (MIT) and a biotechnology company, Visterra, to develop a single treatment for all four serotypes of dengue.

The team started with a naturally occurring antibody that reacted only against limited number of types of dengue virus. Using that antibody as a scaffold, the team engineered a new antibody that reacts against all four types of dengue virus.

The engineering was made possible by computational methods developed in MIT and SMART. This was then confirmed and validated using a detailed crystal structure of the antibody-virus protein complex obtained at NTU, which also provided insights into how the antibody engaged the virus to produce the desired effect.

Using a variety of systems developed in the SMART laboratories in the Campus for Research Excellence And Technological Enterprise (CREATE) (e.g. the SMART humanised mouse model), Duke-NUS and NUS, the team then showed that this novel antibody has the potential to neutralise dengue virus and prevent signs of disease.

Another important feature of this antibody is that it acts on a part of the virus that is not normally targeted by the normal human immune response. This is important as the antibody would not need to compete with but would instead augment the overall natural immune response against dengue virus.

“This interdisciplinary, transnational team has enabled us to address this problem in unique ways,” said Professor Ram Sasisekharan, SMART principal investigator (PI) of the Infectious Diseases Interdisciplinary Research Group (ID IRG), and MIT Professor of Biological Engineering and Health Sciences & Technology, who led the team. “A single laboratory would not have the breadth of expertise to solve this problem on its own.”

“We have each been working on our own areas of interests for years,” added Associate Professor Ooi Eng Eong, deputy director of the Emerging Infectious Diseases Programme at Duke-NUS and SMART co-lead PI of ID IRG. “To be able to take what we have built over the years and put it together to solve a critical medical need, has been very rewarding personally and professionally.”

The Latest on: Dengue vaccine

[google_news title=”” keyword=”dengue vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

The Latest on: Dengue vaccine

Dengue kills 6 in Argentina
on March 29, 2023 at 5:00 pm
Official data on the outbreak of dengue at the national level from August 2022 to March 2023 show a 95% nationwide increase in the number of cases in just one week.
Lab-made antibodies offer potential cure for yellow fever
on March 29, 2023 at 1:16 pm
"Neglected tropical diseases like yellow fever, dengue and Zika are often overlooked by traditional ... The disease is preventable with a highly effective vaccine, which has been available since the ...
Can We Prevent Dengue?
on March 28, 2023 at 7:33 pm
We discussed an important breakthrough with Ramona Sequeira, President of the Global Portfolio Division of Takeda, an investigational dengue vaccine candidate that has been approved for use in the ...
Cases of dengue on the rise in Brazil
on March 28, 2023 at 5:00 pm
The bulletin also confirmed that 112 people have died of dengue, out of 280 who developed the fever, with most cases detected in the states of São Paulo, followed by Goiás, Bahia, Santa Catarina ...
CDC urges caution against dengue fever
on March 28, 2023 at 9:00 am
The Centers for Disease Control (CDC) yesterday reported three serious cases of flu complications and one flu-related death, and advised people to take precautions when traveling, as the number of ...
Philippines donates $20,000 to UNDP’s vaccine program
on March 27, 2023 at 1:31 am
The Philippines has turned over its 2023 contribution worth $20,000 to the International Vaccine Institute, the Department of Foreign Affairs said. The IVI is a non-profit international organization ...
Fogging is enough, and other misconceptions about dengue fever
on March 25, 2023 at 5:32 pm
With dengue having become endemic and Malaysians ... And now, there is news of a vaccine being reviewed,” Lee shared. None of this, she cautions, is an excuse to let down your guard.
Cuba works for a vaccine against dengue fever
on March 24, 2023 at 8:35 pm
In the last decade, dengue has been one of the most prevalent diseases in the Americas. It has shown a cyclical behavior and a tendency to increase, according to international health organizations.
Can AI predict spatiotemporal distribution of dengue fever outbreaks with remote sensing data?
on March 23, 2023 at 9:44 am
Outbreaks of zoonotic diseases, which are those transmitted from animals to humans, are globally on the rise due to climate change. In particular, the spread of diseases transmitted by mosquitoes is ...
Dengue Vaccines Market Size and Forecast till 2028
on March 20, 2023 at 10:44 pm
Mar 20, 2023 (The Expresswire) -- The "Dengue Vaccines Market" Study Describes how the technology industry is evolving and how major and emerging players in the industry are responding to long ...